Correlation Between Revelation Biosciences and Cyclerion Therapeutics

Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Revelation Biosciences and Cyclerion Therapeutics, you can compare the effects of market volatilities on Revelation Biosciences and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Cyclerion Therapeutics.

Diversification Opportunities for Revelation Biosciences and Cyclerion Therapeutics

-0.41

Correlation Coefficient

Revelation Biosciences  Cyclerion Therapeutics

Very good diversification

The 3 months correlation between Revelation and Cyclerion is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Cyclerion Therapeutics go up and down completely randomly.

Pair Corralation between Revelation Biosciences and Cyclerion Therapeutics

Assuming the 90 days horizon Revelation Biosciences is expected to under-perform the Cyclerion Therapeutics. In addition to that, Revelation Biosciences is 1.29 times more volatile than Cyclerion Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Cyclerion Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest  288.00  in Cyclerion Therapeutics on June 25, 2024 and sell it today you would earn a total of  5.00  from holding Cyclerion Therapeutics or generate 1.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Revelation Biosciences  vs.  Cyclerion Therapeutics

Revelation Biosciences

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Revelation Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Revelation Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Cyclerion Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cyclerion Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Cyclerion Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Revelation Biosciences and Cyclerion Therapeutics

The main advantage of trading using opposite Revelation Biosciences and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.

The idea behind Revelation Biosciences and Cyclerion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .